公司资料
Zai Lab Limited 股价、新闻与催化剂
- 股票代码:
- ZLAB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- China and listed in the U
股票表现
25.50 USD (-3.19%)
收盘价
最后更新: 2026年10月1日
1.93B USD
市值
股价为何变动
截至 2026年10月1日，ZLAB 下跌 3.19%，收于 $25.50。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Zai Lab is a global biopharmaceutical company focused on oncology, infectious disease, and autoimmune disease. Its story combines commercial execution in Asia with a broad development pipeline and international reach.
所在地与行业分类
Zai Lab is headquartered in China and listed in the U.S. market. It sits in global specialty biopharma with a strong oncology footprint.
商业模式特征
The company generates value through product commercialization, pipeline progress, and strategic partnerships across major therapeutic areas. Investors watch revenue growth, approvals, and portfolio expansion.
生物医药行业定位
Zai Lab occupies a top-tier global biopharma niche. It is more durable than a small-cap biotech name, but pipeline and commercial catalysts still matter a lot.
未来催化剂
- Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise. The stock moves on execution across multiple assets.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。